Tutorial 1
Tutorial 1
2. HiFlyer Corporation does not currently have any debt. Its tax rate is .4 and its unlevered beta is
estimated by examining comparable companies to be 2.0. The 10-year Treasury bond rate is 6.25%
and the historical risk premium over the risk free rate is 5.5%. Next year, HiFlyer expects to borrow up
to 75% of its equity value to fund future growth.
3. Abbreviated financial statements are given for Fletcher Corporation in the following table:
2010 2011
Revenues $600.0 $690.0
Operating expenses 520.0 600.0
Depreciation 16.0 18.0
Earnings before 64.0 72.0
interest and taxes
Less Interest Expense 5.0 5.0
Less: Taxes 23.6 26.8
Equals: Net income 35.4 40.2
Addendum:
Yearend working 150 200
capital
Principal repayment 25.0 25.0
Capital expenditures 20 10
Yearend working capital in 2009 was $160 million and the firm’s marginal tax rate is 40% in both
2010 and 2011. Estimate the following for 2010 and 2011:
a. Free cash flow to equity.
b. Free cash flow to the firm.
4. No Growth Incorporated had operating income before interest and taxes in 2011 of $220 million. The
firm was expected to generate this level of operating income indefinitely. The firm had depreciation
expense of $10 million that same year. Capital spending totaled $20 million during 2011. At the end of
2010 and 2011, working capital totaled $70 and $80 million, respectively. The firm’s combined
marginal state, local, and federal tax rate was 40% and its debt outstanding had a market value of $1.2
billion. The 10-year Treasury bond rate is 5% and the borrowing rate for companies exhibiting levels
of creditworthiness similar to No Growth is 7%. The historical risk premium for stocks over the risk
free rate of return is 5.5%. No Growth’s beta was estimated to be 1.0. The firm had 2,500,000
common shares outstanding at the end of 2011. No Growth’s target debt to total capital ratio is 30%.
5. Carlisle Enterprises, a specialty pharmaceutical manufacturer, has been losing market share for three
years since several key patents have expired. The free cash flow to the firm in 2002 was $10 million.
This figure is expected to decline rapidly as more competitive generic drugs enter the market.
Projected cash flows for the next five years are $8.5 million, $7.0 million, $5 million, $2.0 million, and
$.5 million. Cash flow after the fifth year is expected to be negligible. The firm’s board has decided to
sell the firm to a larger pharmaceutical company interested in using Carlisle’s product offering to fill
gaps in its own product offering until it can develop similar drugs. Carlisle’s cost of capital is 15%.
What purchase price must Carlisle obtain to earn its cost of capital?
6. Ergo Unlimited current year’s free cash flow is $10 million. It is projected to grow at 20% per year for
the next five years. It is expected to grow at a more modest 5% beyond the fifth year. The firm
estimates that its cost of capital is 12% during the next five years and then will drop to 10% beyond the
fifth year as the business matures. Estimate the firm’s current market value.
7. In the year in which it intends to go public, a firm has revenues of $20 million and net income after
taxes of $2 million. The firm has no debt, and revenue is expected to grow at 20% annually for the next
five years and 5% annually thereafter. Net profit margins are expected remain constant throughout.
Capital expenditures are expected to grow in line with depreciation and working capital requirements
are minimal. The average beta of a publicly traded company in this industry is 1.50 and the average
debt/equity ratio is 20%. The firm is managed very conservatively and does not intend to borrow
through the foreseeable future. The Treasury bond rate is 6% and the tax rate is 40%. The normal
spread between the return on stocks and the risk-free rate of return is believed to be 5.5%. Reflecting
the slower growth rate in the sixth year and beyond, the firm’s discount rate is expected to decline to
the industry average cost of capital of 10.4%. Estimate the value of the firm’s equity.
8. The following information is available for two different common stocks: company A and
Company B.
Company A Company B
Beta 1.3 .8
Risk-free return 7% 7%
9. You have been asked to estimate the beta of a high-technology firm, which has three
divisions with the following characteristics.
and for the software division is $3.1 million. If the total firm and the software
division are
expected to grow at the same 8% rate into the foreseeable future, estimate the
market value of the